Key Facts

PIPS Key Facts
Active Substance
  • Islatravir
Invented Name
Not yet available
PIP Number MHRA-100111-PIP01-21
Pharmaceutical form(s)
  • Tablet
  • Age appropriate solid dosage form
Therapeutic area
Therapeutic area:
  • Infectious diseases
Conditions / Indications
Conditions / Indications:
  • Treatment of human immunodeficiency virus-1 (HIV-1) infection.
Route(s) of administration
Route(s) of administration:
  • Oral use
PIP applicant
Decision Type
Decision Type
P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s)
Compliance Check
Compliance Check
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

PIPS Decision Documents
Decision Document Decision Document on a Paediatric Investigation Plan (PIP):DORAVIRINE;Islatravir.pdf
Published Date 17/12/2021